BridgeMD
Tests treatment safety and results for Hip Surgery
Official title Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Who Have Undergone Hip Surgery
ClinicalTrials.gov ID: NCT07147491
What this study is testing
- What it's testing
- Gait is an essential daily activity performed through the complex coordination of the central and peripheral nervous systems and the musculoskeletal system. Gait disorders can negatively affect quality of life, increase the risk of falls, decrease the ability to perform daily activities, and limit physical activity.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Individuals aged 19 or older
- Individuals who have undergone hip surgery due to hip osteoarthritis, avascular necrosis of the femoral head, or hip fracture
- Individuals who are at least two days post-hip surgery and are assessed to be medically stable
- Individuals who have adequate cognitive ability (Korean Mini-Mental State Examination score ≥ 20)
- Individuals able to sit at the edge of a bed without assistance and stand for 10 seconds regardless of support
You likely can't join if
- Individuals who, after undergoing hip surgery, present with exudate at the surgical site or report symptoms such as heat, redness, swelling, or...
- Individuals who have contraindications for lower limb weight-bearing such as severe joint contractures, osteoporosis, or untreated fractures
- Individuals who have progressive or unstable brain diseases or neurological paralysis from stroke
- Individuals who have active infections or open wounds hindering device use
- Individuals who have significant leg length discrepancies
- Individuals who have severe deformities or contractures in the lower extremities
See the full eligibility criteria
- Individuals aged 19 or older
- Individuals who have undergone hip surgery due to hip osteoarthritis, avascular necrosis of the femoral head, or hip fracture
- Individuals who are at least two days post-hip surgery and are assessed to be medically stable
- Individuals who have adequate cognitive ability (Korean Mini-Mental State Examination score ≥ 20)
- Individuals able to sit at the edge of a bed without assistance and stand for 10 seconds regardless of support
- Individuals who are Functional Ambulatory Category (FAC) score of 1-3
- Individuals who visited Yongin Severance Hospital, understood the study, and signed informed consent
- Individuals who, after undergoing hip surgery, present with exudate at the surgical site or report symptoms such as heat, redness, swelling, or severe pain at the affected area
- Individuals who have contraindications for lower limb weight-bearing such as severe joint contractures, osteoporosis, or untreated fractures
- Individuals who have progressive or unstable brain diseases or neurological paralysis from stroke
- Individuals who have active infections or open wounds hindering device use
- Individuals who have significant leg length discrepancies
- Individuals who have severe deformities or contractures in the lower extremities
- Individuals who have history of poliomyelitis
- Individuals inable to maintain seated or standing positions independently
- Individuals who have severe spasticity (Modified Ashworth Scale grade ≥ 2)
- Individuals who have bone metastases from cancer
- Individuals who have severe internal diseases affecting device use (e.g., cardiovascular or respiratory diseases)
- Individuals who have cognitive impairments preventing cooperation with device use
- Individuals who have complaints of device-related side effects or potential rehabilitation discontinuation (e.g., severe obesity, skeletal deformity)
- Patients who are determined to be pregnant or potentially pregnant based on the medical interview
- Individuals who have any other clinically significant findings deemed inappropriate by the investigator
The study team makes the final eligibility decision.
Where it's taking place
- Yongin-si, Gyeonggi-do, South Korea, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yongin-si, Gyeonggi-do, South Korea, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.